KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) FCF Margin (2016 - 2025)

Historic FCF Margin for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 16.64%.

  • West Pharmaceutical Services' FCF Margin rose 34100.0% to 16.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.56%, marking a year-over-year increase of 13800.0%. This contributed to the annual value of 9.55% for FY2024, which is 45000.0% down from last year.
  • Latest data reveals that West Pharmaceutical Services reported FCF Margin of 16.64% as of Q3 2025, which was up 34100.0% from 13.29% recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' FCF Margin ranged from a high of 19.18% in Q4 2022 and a low of 3.97% during Q1 2024
  • Over the past 5 years, West Pharmaceutical Services' median FCF Margin value was 12.44% (recorded in 2023), while the average stood at 12.61%.
  • As far as peak fluctuations go, West Pharmaceutical Services' FCF Margin plummeted by -89600bps in 2021, and later skyrocketed by 76400bps in 2022.
  • West Pharmaceutical Services' FCF Margin (Quarter) stood at 11.54% in 2021, then soared by 66bps to 19.18% in 2022, then dropped by -7bps to 17.81% in 2023, then crashed by -36bps to 11.38% in 2024, then soared by 46bps to 16.64% in 2025.
  • Its FCF Margin stands at 16.64% for Q3 2025, versus 13.29% for Q2 2025 and 8.32% for Q1 2025.